Cargando…

Mobile Phones, Brain Tumors, and the Interphone Study: Where Are We Now?

Background: In the past 15 years, mobile telephone use has evolved from an uncommon activity to one with > 4.6 billion subscriptions worldwide. However, there is public concern about the possibility that mobile phones might cause cancer, especially brain tumors. Objectives: We reviewed the eviden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swerdlow, Anthony J., Feychting, Maria, Green, Adele C., Kheifets, Leeka, Savitz, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Institute of Environmental Health Sciences 2011
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226506/ https://www.ncbi.nlm.nih.gov/pubmed/22171384 http://dx.doi.org/10.1289/ehp.1103693

Ejemplares similares

Epidemiology of Health Effects of Radiofrequency Exposure
por: Ahlbom, Anders, et al.
Publicado: (2004)

Epidemiology of Radiofrequency Exposure: Ahlbom et al. Respond
por: Ahlbom, Anders, et al.
Publicado: (2005)

Estimation of RF energy absorbed in the brain from mobile phones in the Interphone Study
por: Cardis, E, et al.
Publicado: (2011)

Mobile phone use and risk of acoustic neuroma: results of the Interphone case–control study in five North European countries
por: Schoemaker, M J, et al.
Publicado: (2005)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Ventilator-associated tracheobronchitis: where are we now?
por: Nseir, Saad, et al.
Publicado: (2014)

Genetic counseling globally: Where are we now?
por: Ormond, Kelly E., et al.
Publicado: (2018)

Commentary: Call me on my mobile phone…or better not?—a look at the INTERPHONE study results
por: Saracci, Rodolfo, et al.
Publicado: (2010)

Commentary: Call me on my mobile phone … or better not?—a look at the INTERPHONE study results
por: Saracci, Rodolfo, et al.
Publicado: (2010)

Risk of brain tumours in relation to estimated RF dose from mobile phones: results from five Interphone countries
por: Cardis, E, et al.
Publicado: (2011)

Neoadjuvant treatment of rectal cancer: where are we now?
por: Kalyan, Aparna, et al.
Publicado: (2016)

COVID-19 – Where should we go now?
por: Allen, Claire, et al.
Publicado: (2020)

Childhood brain tumours and use of mobile phones: comparison of a case–control study with incidence data
por: Aydin, Denis, et al.
Publicado: (2012)

Conduction System Pacing: Where Are We Now?
por: Niazi, Imran
Publicado: (2022)

Anti-cytokine therapy in fibrosing alveolitis: where are we now?
por: Millar, Ann
Publicado: (2000)

Medically Complex Living Kidney Donors: Where Are We Now?
por: Textor, Stephen C.
Publicado: (2019)

Polygenic risk scores for complex diseases: where are we now?
por: Loh, Marie, et al.
Publicado: (2023)

Mechanical Thrombectomy- Where Do We Stand Now ?
por: Chakraborty, Debabrata, et al.
Publicado: (2022)

Mobile phone use and risk of acoustic neuroma: results of the interphone case–control study in five North European countries
por: Hardell, L, et al.
Publicado: (2006)

Social radiology: Where to now?
por: Ho, ELM
Publicado: (2012)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

World Health Organization AWaRe framework for antibiotic stewardship: Where are we now and where do we need to go? An expert viewpoint
por: Mudenda, Steward, et al.
Publicado: (2023)

Where are we now?
Publicado: (1977)

Diagnostic radiological examinations and risk of intracranial tumours in adults—findings from the Interphone Study
por: Auvinen, Anssi, et al.
Publicado: (2021)

5-α reductase inhibitors and prostate cancer prevention: where do we turn now?
por: Hamilton, Robert J, et al.
Publicado: (2011)

Extension for Community Healthcare Outcomes (ECHO) Telementoring in the Military: Where We Are Now, Opportunities and Challenges
por: Katzman, Joanna, et al.
Publicado: (2021)

Corrigendum to: Diagnostic radiological examinations and risk of intracranial tumours in adults—findings from the interphone study
por: Auvinen, Anssi, et al.
Publicado: (2021)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

Surgically-induced brain injury: where are we now?
por: Travis, Zachary D., et al.
Publicado: (2019)

Mobile phone use and risk for intracranial tumors
por: Alexiou, George A., et al.
Publicado: (2015)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Les interphones dans la zone neutrino
por: Robert, J
Publicado: (1969)

Health in All policies: what do we mean and where are we now?
por: Green, L
Publicado: (2022)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n074731pmjf5g4pbuh74le7hb5